89521989486394x3 dn 7yearold male with lissencephaly Note These example CNVs have been created for educational purposes in order to ensure that each evidence type in the scoring matrices are utilized across the entire set no single CNV will necessarily cover all evidence types These a ID: 929729
Download Presentation The PPT/PDF document "Case O arr [GRCh37] 4p16.1" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Case Oarr[GRCh37] 4p16.1(8952198_9486394)x3 dn
7-year-old male with lissencephaly
Note: These example CNVs have been created for educational purposes in order to ensure that each evidence type in the scoring matrices are utilized across the entire set (no single CNV will necessarily cover all evidence types). These are not actual CNVs that have been observed in a laboratory setting. As such, please evaluate the coordinates as given, regardless of other considerations that may apply in the actual clinical laboratory setting. For example, if your CNV is below the size cutoff your laboratory uses on a daily basis, please disregard this for the sake of this exercise and evaluate the content within the provided coordinates. Assume that the CNV is technically valid.
Slide2Clinical Informationarr[GRCh37] 4p16.1(8952198_9486394)x3
dn7-year-old male with lissencephalyVariant is de novoUse the GAIN scoring metric
Slide3Section 1: Initial Assessment of Genomic Content
Case O
Genes Involved
Would apply category 1A (contains protein-coding or other known functionally important elements), as this duplication includes protein-coding genes.
0 points; continue evaluation
Total: 0 points
Slide4Section 2: Overlap with Established TS, HI, or Benign Genes/Genomic Regions
Case O
ClinGen Curated Track = EMPTY
Segmental Duplications
CNV O does not overlap with any current ClinGen curated genes/regions. Note that it does fall within a cluster of segmental duplications.
Total: 0 points
Slide5Section 3: Evaluation of Gene Number
Technically, CNV O contains 22 protein-coding genes.
HOWEVER, many of these genes are within the same family (ubiquitin specific peptidase 17 like family).
None of these genes have been associated with disease, so would only count them as 1.
Regardless, this still falls within Category 3A, 0 points.
Total: 0 points
Slide6Section 4: Detailed Evaluation of Genomic Content
As of July 2020, DEF31B1, FAM90A26, and the genes in the UPS17L gene family have not been associated with human disease per OMIMBasic literature search does not reveal any convincing evidenceCNV O was located in a cluster of segmental duplicationsCheck for evidence of population variation.
Approximate length of CNV O
DEF31B1
FAM90A26
These three variants are similar in size and genomic content to CNV O. What are their frequencies?
Slide8These variants have been observed on 1168, 1122, and 645 alleles, respectively (out of ~21,000 alleles). Their allele frequencies range from 3.0% to 5.4%.
Slide9All 3 variants have passed quality filters
For each variant, a sufficient number of alleles has been studied (>2000 alleles from a continental population).
While these variants have been observed within most of the studied populations, they are the most frequent in Africans, with an allele frequency between 6.5-11.5%.
This is too high to be a plausible cause for a rare anomaly such as lissencephaly.
Apply Category 4O, -1 points
Total: -1 points
Slide10Section 5: Evaluation of Inheritance Pattern/Family History for Patient Being Studied
Our patient is a 7-year-old male with lissencephalyRegardless of inheritance information, similar duplications are observed frequently in the general population, at frequencies too high to be a plausible cause for this phenotype.The variant is de novo.This does not change the evidence discussed above, or our assessment of the variant. No positive points should be awarded for this fact.
Total: -1 points
Slide11ConclusionClassification: BenignSimilar duplications are observed in the general population at frequencies too high to be a plausible cause for lissencephaly.
Consider additional testing to investigate other potential causes for lissencephaly in this individual.